Axogen Shows Its Nerve as Sales Climb 26 Percent

By Robin YoungNovember 9, 2026 1 min read Premium comments

Courtesy of Axogen Corporation

#axogen3Q26 earnings report

For the quarter ended September 30, 2026, Axogen, the peripheral nerve repair specialist, reported sales of $75.8 million, up 26.2% from $60.1 million a year earlier. Net income rose to $2.3 million, or $0.04 per diluted share, from $708,000, or $0.01. Results were released October 28.

Join 13,000+ Subscribers

Get unlimited access to OTW reporting, member discussions, and the weekly newsletter.

13,000+ subscribers

Every OTW article, fully unlocked
Member comments and discussion
The weekly orthopedic business briefing

React: